Enterprise Value
4.376M
Cash
36.15M
Avg Qtr Burn
-3.316M
Short % of Float
0.33%
Insider Ownership
23.65%
Institutional Own.
14.01%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MDNA11 (IL-2) Details Cancer, Cold tumors | Phase 1/2 Data readout | |
MDNA55 (IL-4 Superkine) Details Glioblastoma, Cancer | Failed Discontinued |